Last reviewed · How we verify
BB-10901
At a glance
| Generic name | BB-10901 |
|---|---|
| Also known as | IMGN901 |
| Sponsor | ImmunoGen, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Anemia
- Anorexia
- Dehydration
- Fatigue
- Hypertension
- Nausea
- Non-cardiac chest pain
- Abdominal pain
- Alanine aminotransferase increased
- Atelectasis
- Catheter related infection
- Dyspnea
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BB-10901 CI brief — competitive landscape report
- BB-10901 updates RSS · CI watch RSS
- ImmunoGen, Inc. portfolio CI